Koninklijke Philips (RYLPF) Non-Current Deffered Revenue (2017 - 2026)
Koninklijke Philips (RYLPF) recorded quarterly Non-Current Deffered Revenue of $512.8 million in Q1 2026, down 3.82% quarter-over-quarter from $533.1 million in Q4 2025, and up 18.32% on a YoY basis from $433.4 million in Q1 2025.
Koninklijke Philips (RYLPF) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends
Koninklijke Philips' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $512.8 million for Q1 2026.
- In Q1 2026, Non-Current Deffered Revenue rose 18.32% year-over-year to $512.8 million; the TTM figure through Mar 2026 stood at $512.8 million (up 18.32% YoY), while the FY2025 annual figure was $533.1 million, up 15.76% from the prior year.
- Non-Current Deffered Revenue was $512.8 million for Q1 2026 at Koninklijke Philips, down from $533.1 million in the prior quarter.
- In the past five years, Non-Current Deffered Revenue ranged from a high of $537.9 million in Q2 2023 to a low of $433.4 million in Q1 2025.
- Historically, Non-Current Deffered Revenue has averaged $496.6 million across 5 years, with a median of $504.6 million in 2023.
- The sharpest annual moves came in 2024 and 2026: Non-Current Deffered Revenue slipped 10.71% in 2024, then gained 18.32% in 2026.
- A 5-year view of Non-Current Deffered Revenue shows it stood at $525.4 million in 2022, then declined by 3.96% to $504.6 million in 2023, then fell by 8.73% to $460.6 million in 2024, then increased by 15.76% to $533.1 million in 2025, then fell by 3.82% to $512.8 million in 2026.
- The last three Non-Current Deffered Revenue figures came in at $512.8 million (Q1 2026), $533.1 million (Q4 2025), and $485.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | - |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 512.79 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | - |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | 512.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 512.79 Mn |
| Dec 31, 2025 | 533.13 Mn |
| Sep 30, 2025 | 485.16 Mn |
| Jun 30, 2025 | 466.37 Mn |
| Mar 31, 2025 | 433.38 Mn |
| Dec 31, 2024 | 460.56 Mn |
| Jun 30, 2024 | 480.29 Mn |
| Dec 31, 2023 | 504.62 Mn |
| Jun 30, 2023 | 537.93 Mn |
| Dec 31, 2022 | 525.43 Mn |
| Jun 30, 2022 | 522.86 Mn |
| Dec 31, 2021 | 510.21 Mn |
| Jun 30, 2021 | 507.00 Mn |
| Dec 31, 2020 | 480.49 Mn |
| Jun 30, 2020 | 395.42 Mn |
| Dec 31, 2019 | 385.20 Mn |
| Jun 30, 2019 | 326.98 Mn |
| Dec 31, 2018 | 257.96 Mn |
| Jun 30, 2018 | 263.75 Mn |
| Dec 31, 2017 | 293.18 Mn |